key highlights in mpns at ash 2023: novel agents & combinations, ongoing clinical trials, and more
Published 6 months ago • 1.1K plays • Length 16:35Download video MP4
Download video MP3
Similar videos
-
13:31
key highlights in mpns: novel agents, combinations, and the potential role of immunotherapy
-
11:42
thalassemia highlights at ash 2023: novel therapies, trial updates & the value of precision medicine
-
3:21
long-term outcomes from key clinical trials presented at ash 2023
-
6:48
key trials in multiple myeloma presented at ash 2023: take home messages
-
0:45
key trials in cll and designing a concept for treatment
-
2:43
the management of advanced phase mpns
-
3:19
key clinical trials in mds taking place in the us
-
1:46:07
hematology lecture
-
30:53
hematology keywoord review 2019 - (dr. rebel)
-
35:31
machine learning and artificial intelligence in hematology
-
1:39
session highlights: the value of clinical hematology research groups
-
1:25
highlights on myelofibrosis from ash
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
1:19
what's on the horizon for the treatment of mpns?
-
3:16
new mpn clinical trials & drugs in 2021
-
1:52
the importance of symptom management in mpns
-
1:49
key clinical trials in cll at ash 2020
-
2:41
an overview of the latest advances in hematology
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
8:34
hct in mds: cell source and conditioning type
-
5:12
ash2021: what are the key highlights in mpn?